Search hospitals > South Carolina > Charleston
Medical University of South Carolina
Claim this profileCharleston, South Carolina 29401
Global Leader in Lung Cancer
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Stroke
Conducts research for Heart Failure
2284 reported clinical trials
177 medical researchers
Summary
Medical University of South Carolina is a medical facility located in Charleston, South Carolina. This center is recognized for care of Lung Cancer, Cancer, Breast Cancer, Stroke, Heart Failure and other specialties. Medical University of South Carolina is involved with conducting 2,284 clinical trials across 2,099 conditions. There are 177 research doctors associated with this hospital, such as Jacqueline M. Kraveka, Gregory Cote, MD, Michael Gold, MD, and Mariam Alexander.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
EGFR positive
2Cancer
Global LeaderStage IV
Stage III
Stage I
Top PIs
Jacqueline M. KravekaMedical University of South Carolina6 years of reported clinical research
Studies Brain Tumor
Studies Neuroblastoma
35 reported clinical trials
88 drugs studied
Gregory Cote, MDMassachusetts General Hospital7 years of reported clinical research
Studies Cancer
Studies Soft Tissue Sarcoma
19 reported clinical trials
27 drugs studied
Michael Gold, MDOklahoma Cancer Specialists and Research Institute5 years of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
19 reported clinical trials
33 drugs studied
Mariam AlexanderMedical University of South Carolina4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
17 reported clinical trials
28 drugs studied
Clinical Trials running at Medical University of South Carolina
Lung Cancer
Skin Cancer
Breast Cancer
Multiple Myeloma
Cancer
Testicular cancer
Crohn's Disease
Neuroblastoma
Breast cancer
Stroke
Telisotuzumab Vedotin vs. Docetaxel
for Non-Small Cell Lung Cancer
This trial is testing a new drug called telisotuzumab vedotin to see if it can treat a specific type of lung cancer better than an existing drug. The study focuses on adults whose lung cancer has not responded to previous treatments. The new drug targets and kills cancer cells by attaching to a specific protein on their surface.
Recruiting2 awards Phase 312 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Medical University of South Carolina?
Medical University of South Carolina is a medical facility located in Charleston, South Carolina. This center is recognized for care of Lung Cancer, Cancer, Breast Cancer, Stroke, Heart Failure and other specialties. Medical University of South Carolina is involved with conducting 2,284 clinical trials across 2,099 conditions. There are 177 research doctors associated with this hospital, such as Jacqueline M. Kraveka, Gregory Cote, MD, Michael Gold, MD, and Mariam Alexander.
Where is Medical University of South Carolina located?
**Medical University of South Carolina (MUSC) Hospital**
- **Location:** 171 Ashley Ave, Charleston, SC 29425
- **Contact:** 843-792-1414
Who should I call to ask about financial aid or insurance network?
**Medical University of South Carolina (MUSC) Hospital Contact Information:**
- **General Inquiries:** Call 843-792-2300.
- **Financial Assistance:** Contact customer service at 843-792-2311 or 800-598-0624, Monday - Friday, 8 a.m. - 4:30 p.m.
- **Insurance Inquiries:**
- **Student Health Insurance Plan:** Administered through Blue Cross Blue Shield of South Carolina, call 1-855-844-3015.
- **Supplemental Retirement and Life Insurance:** Contact Sharon Goodmon-Brown at 843-345-0976.
- **Student Financial Aid:** Email finaid@musc.edu or use the Student Self-Service Portal to contact your assigned counselor.
What insurance does Medical University of South Carolina accept?
The Medical University of South Carolina (MUSC) accepts several insurance plans, including the MUSC Health Plan, a PPO with a network of hospitals, doctors, and service providers offering discounted fees. MUSC also provides a school-sponsored health insurance plan for students, administered by Academic HealthPlans (AHP) and underwritten by Blue Cross Blue Shield of South Carolina. Patients are encouraged to verify if their insurance covers MUSC Health services and to request inclusion in their network if not already covered.
At the University of South Carolina, all students must have health insurance. This includes undergraduates taking six or more hours and paying the student health fee, graduate students taking six hours or more, graduate students with assistantships, USC School of Medicine students enrolled in one or more hours, and all international students. The Student Health Insurance Plan is the only in-network plan at Student Health, and waiving the University Sponsored health insurance plan may result in out-of-network costs for some services at Student Health.
What awards or recognition has Medical University of South Carolina received?
The Medical University of South Carolina (MUSC) hospital, located in Charleston, South Carolina, is celebrated for its pioneering biomedical research and clinical trials, led by a team of internationally recognized faculty and scientists. MUSC has been recognized for its leadership in Inclusive Excellence, notably receiving the Earl B. Higgins Award. The institution is dedicated to transforming medical treatments and advancing medical understanding through the collaborative efforts of its scientists and physicians.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.